All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.
about
DLC-1: a Rho GTPase-activating protein and tumour suppressorInhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell linesInduction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2Liarozole inhibits transforming growth factor-β3--mediated extracellular matrix formation in human three-dimensional leiomyoma cultures.Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro.Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.The Retinoid Agonist Tazarotene Promotes Angiogenesis and Wound Healing.Retinoid and TGF-β families: crosstalk in development, neoplasia, immunity, and tissue repair.Retinoic acid treatment of human leiomyoma cells transformed the cell phenotype to one strongly resembling myometrial cells.Treatment of relapsed Wilms tumors: lessons learned.Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer.Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells.The predictive value of transforming growth factor-β in Wilms tumor immunopathogenesis.DrugTargetInspector: An assistance tool for patient treatment stratification.Genetic variations in monocyte chemoattractant protein-1 and susceptibility to ovarian cancer.Expression profiling of Wilms tumors reveals new candidate genes for different clinical parameters.Characterization of primary Wilms tumor cultures as an in vitro model.
P2860
Q23917637-8F8EF449-9261-47AD-BA23-E08BEAD873B5Q24678585-AE5017A7-B1C4-4683-9496-7A1EE03B30BCQ30438371-0D094172-C8C8-481C-99A5-C759958D8630Q34125193-2A4CBC22-9C23-405B-BE0D-7BB5EF631FFFQ35215704-CA29F714-8E90-412B-BF77-5F61DF1C1169Q35617537-5BAE902E-ABC0-4819-991F-C9BD9F14EB98Q35685819-A6234712-0C91-4D34-86B3-34E95988281FQ36092050-61237411-F144-4B74-9B35-B389A294DACFQ36124246-9FBB7D22-A93E-4CE8-8BD0-42FF73C820BAQ37029528-F0884F21-12EA-4A0E-BC2E-72A7BEB31ADCQ37642795-2EC76EB4-3298-4A70-962F-B550CF7ED1E1Q38212057-4FE13EC2-251F-4CD1-BD01-64ACC50D7EF4Q38349181-812755CD-6D43-40E3-BCD0-BA8CFB2B99CBQ39290714-0E42C5F9-2D24-4977-BA68-5FEF63493516Q40392337-97286EFE-E1A6-4B62-8AD8-70CE88A3DF2CQ46026383-3FBC00F6-F8A2-47D9-97A4-1F2C42A15930Q46803214-0162AFD3-50AD-410C-8681-3CD46629FDF2Q51849264-47C0E758-3719-4915-85CC-17AB8A7CE41D
P2860
All-trans retinoic acid treatment of Wilms tumor cells reverses expression of genes associated with high risk and relapse in vivo.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
All-trans retinoic acid treatm ...... high risk and relapse in vivo.
@en
type
label
All-trans retinoic acid treatm ...... high risk and relapse in vivo.
@en
prefLabel
All-trans retinoic acid treatm ...... high risk and relapse in vivo.
@en
P2093
P2860
P50
P356
P1433
P1476
All-trans retinoic acid treatm ...... high risk and relapse in vivo.
@en
P2093
Birgit Samans
Birgit Zirn
Christian Spangenberg
P2860
P2888
P304
P356
10.1038/SJ.ONC.1208725
P407
P577
2005-08-01T00:00:00Z
P5875
P6179
1011629536